The California Department of Health Care Services (DHCS) has selected Pear Therapeutics, Inc. to support the implementation of the Recovery Incentives: California's Contingency Management Program. Contingency management is an evidence-based, cost-effective treatment that provides motivational incentives to treat individuals living with stimulant use disorder and support their path to recovery. The pilot program will allow eligible Medi-Cal members, across 24 counties in California, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services.

Pear Therapeutics will partner with DHCS to deliver, implement, and manage this program, specifically by managing the electronic tracking and distribution of incentives to Medi-Cal members who participate in this contingency management pilot. As stimulant use disorder continues to be pervasive across the United States, Pear Therapeutics is committed to providing individuals across the country with access to its innovative treatment options.